it's not clear how well they'll stack up against current migraine therapies, because head-to-head studies haven't been done.
.
originally published on may 17, 2018 10:46 pm
.
�the kind of review being proposed does not, at least initially, appear to bring anything new or needed to is already a robust system of oversight,� mogulof said in the statement.
.
.